top of page
fondo s-03.png

Our Services

HSG00186_HSG WEB 7.2-04.png

01

Commercial Strategy

HSG00186_HSG WEB 7.2-05.png

Corporate Development

02

HSG00186_HSG WEB 7.2-06.png

03

Portfolio, R&D Strategy

+ Market Analysis, Product Forecasting, and Market Access

Qualitative primary market research with MDs, payers, access experts, patients; quantitative research include conjoint; deterministic and probabilistic forecasting; patient journey/flow modeling

+ Commercialization Strategy 
TPP development; go to market; brand strategy; positioning; value proposition development; competitor mapping

+ Strategic Competitive Intelligence (CI)

Strategic distillation of data, trends

+ Strategy

Growth roadmaps; potential partner/target evaluations; thought partnership

 

+ Storytelling 

Pitch decks and decision decks for investors, partners, governance, Boards, collaborators; S-1 groundwork and writing (US); CIM (confidential information memorandum) groundwork, writing

+ Deal Facilitation and Support

Cross-border/sector outreach; due diligence (functional deep-dives, aNPVs, market research); deal comps/benchmarks, process management

+ Asset Strategy

Go/No Go decks; Scenario analysis, decision trees; indication selection; aNPV analysis; MedTech strategy; PMDA (Japan) & NMPA (China) planning, facilitation)

+ Portfolio Management 

Prioritization of current and/or new investments

+ Portfolio Growth Strategy

Disease area strategy; platform or medtech strategy

Disease areas

We have expertise and project experience across a wide range of disease areas: 

​Acute ischemic stroke

Anticoagulation
Beta-thalassemia
Congestive heart failure 
Dilated cardiomyopathy
Hemophilia
LDL lowering (PCSK9)
Myocardial infarction
Peripheral vascular disease
Subarachnoid hemorrhage

Cardiovascular

Autoimmune hepatitis
Celiac disease (refractory)
Crohn’s disease (CD)
Eosinophilic esophagitis
Inflammatory bowel disease (Crohn's diseases, Ulcerative colitis)
Microscopic colitis
Nonalcoholic steatohepatitis (NASH)
Post-surgical recurrence of CD
Primary sclerosing cholangitis
Ulcerative Colitis

Gastroenterology
& Liver

Gram positive bacteria
HIV/AIDS
Hepatitis B virus
Hepatitis C virus
Influenza
Inpatient and outpatient
Multi-drug resistant bacteria
Treatment, PrEP, PEP
Tuberculosis
​Gram negative bacteria

Infectious 
disease

Antibody mediated rejection (AMR)
C3G
DDD
ESRD
FSGS
IgAN
Lupus nephritis
Nephropathies
Renal transplant
Secondary hyperparathyroidism
​Chronic kidney disease

Nephrology

Alzheimer’s disease
Amyotrophic lateral sclerosis
Chronic inflammatory demyelinating polyneuropathy (CIDP)
Gaucher's Type 2 and 3
Guillain-Barre syndrome
Hunter Syndrome
Hurler syndrome
Krabbe disease
Metachromatic LD
Multiple sclerosis
Myasthenia gravis
Niemann-Pick Type A
Parkinson’s disease
Sanfilippo IIIB

Neurology

Acute lymphoblastic leukemia
Acute myeloid leukemia
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Essential thrombocythaemia
Immune thrombocytopenic purpura
Multiple myeloma
Myelodysplastic syndromes
Myelofibrosis
Non-Hodgkin's lymphoma
Polycythemia vera

Oncology – Hematology

Bladder
Brain (glioblastoma multiforme, metastases)
Breast
Colorectal
Gastric
Head and neck
Liver
Lung
Melanoma
Prostate
Renal
Tumor-agnostic biomarker-driven

Oncology –
Solid Tumors

Diabetic macular edema
Diabetic retinopathy
Geographic atrophy
Glaucoma
Neuromyelitis optica (NMO)
Polypoidal choroidal vasculopathy
Retinal vein occlusion
Retinitis pigmentosa
Uveitis
Wet age-related macular degeneration

Ophthalmology

Pain

Wound care

Others

Acute and chronic bronchitis
Acute lung injury/respiratory distress syndrome
Asthma
Bronchiectasis (non-CF)
Bronchopulmonary dysplasia
CF
COPD
COVID-19
Chronic rhinosinusitis
Churg Strauss
Cryptogenic organizing pneumonia
Hypersensitivity pneumonitis
IPAF
IPF
Idiopathic eosinophilic pneumonia
Interstitial lung disease (ILD)
Lung GVHD
Lymphangioleiomyomatosis
Nonspecific interstitial pneumonitis
Primary ciliary dyskinesia
Primary graft dysfunction
Primary pulmonary arterial hypertension
Pulmonary critical care
Pulmonary sarcoidosis
Radiation-induced lung fibrosis

Respiratory

Atopic dermatitis

Bullous pemphingoid

Chronic inflammatory demyelinating polyneuropathy (CIDP)

Dermatomyositis

Lupus nephritis

Neuromyelitis optica (NMO)

Psoriasis

Psoriatic arthritis

Rheumatoid arthritis

Systemic lupus erythematosus

Rheumatology
& Dermatology

ANCA vasculitis 
Antiphospholipid antibody syndrome
Atypical hemolytic uremic syndrome (aHUS)
Bullous pemphigoid
Chronic inflammatory demyelinating polyneuropathy
Dermatomyositis
Guillain Barre syndrome
Krabbe disease
Myasthenia gravis
Paroxysmal nocturnal hemoglobinuria
Sickle cell disease
​MPS II (Hunter Syndrome)

Ultra rare 
diseases

bottom of page